Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Nolan

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Diabetes Care|April 6, 2001
A model-based method for assessing insulin sensitivity from the oral glucose tolerance testA Mari, G Pacini, E Murphy, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 12, 2001
Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTTA Tura, B Ludvik, J J Nolan, et al.
The New England Journal of Medicine|November 3, 1994
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazoneJ J Nolan, B Ludvik, P Beerdsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 23, 2000
Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitusJ J Nolan, N P Jones, R Patwardhan, et al.
Diabetes|September 1, 1995
Effect of obesity on insulin resistance in normal subjects and patients with NIDDMB Ludvik, J J Nolan, J Baloga, et al.
Irish Medical Journal|February 6, 2007
The cost of treating type 2 diabetes (CODEIRE)J J Nolan, D O'Halloran, T J McKenna, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesityJ J Nolan, G Freidenberg, R Henry, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing ageA J Morales, J J Nolan, J C Nelson, et al.
Diabetes|June 1, 1997
Mechanisms of the kinetic defect in insulin action in obesity and NIDDMJ J Nolan, B Ludvik, J Baloga, et al.
Diabetes Care|February 1, 1992
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjectsS L Suter, J J Nolan, P Wallace, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Diabetes Care|April 6, 2001
A model-based method for assessing insulin sensitivity from the oral glucose tolerance testA Mari, G Pacini, E Murphy, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 12, 2001
Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTTA Tura, B Ludvik, J J Nolan, et al.
The New England Journal of Medicine|November 3, 1994
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazoneJ J Nolan, B Ludvik, P Beerdsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 23, 2000
Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitusJ J Nolan, N P Jones, R Patwardhan, et al.
Diabetes|September 1, 1995
Effect of obesity on insulin resistance in normal subjects and patients with NIDDMB Ludvik, J J Nolan, J Baloga, et al.
Irish Medical Journal|February 6, 2007
The cost of treating type 2 diabetes (CODEIRE)J J Nolan, D O'Halloran, T J McKenna, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesityJ J Nolan, G Freidenberg, R Henry, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing ageA J Morales, J J Nolan, J C Nelson, et al.
Diabetes|June 1, 1997
Mechanisms of the kinetic defect in insulin action in obesity and NIDDMJ J Nolan, B Ludvik, J Baloga, et al.
Diabetes Care|February 1, 1992
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjectsS L Suter, J J Nolan, P Wallace, et al.
Pageof 5